Industry trends

Purchasing information

Home page

Industry trends

Aprotinin returns to the market or endangers public life

Aprotinin was recalled to the global market due to the results of BART research. Recently, the relevant personnel of this research said that the decision of European and Canadian regulatory authorities to allow aprotinin to return to the market or the risk of endangering public life safety exists.

2017-07-18

Fosun Pharmaceuticals acquired 74% equity of Gland74 to build an international platform for preparations

Today, the company announced that it signed the Third Amendment with the existing shareholders and related parties of India Gland, adjusting the transaction to: the company invested no more than US $1091.3 million to acquire about 74% of Gland's equity, including the contingent consideration paid for the listing and sale of Gland Enoxaparin in the United States, which did not exceed US $25 million. The termination date of this transaction is extended to October 3, 2017.

2017-09-20

< 1...8 9 10...12 >

Exploring the Sweet Side of Anhydrous Sodium Saccharin in Various Industries

2025-12-29

The Sweet Science Behind Anhydrous Sodium Saccharin

2025-12-26

Sweet Success: Industry Case Studies on Saccharin Sodium

2025-12-23

The Sweet Science Behind Saccharin Sodium: Unpacking the Myths and Facts

2025-12-20

Bilirubin: The Unsung Hero of Industry Insights

2025-12-17

Bilirubin: The Unsung Hero of Your Health

2025-12-14

图片名称

©2022 Jiangxi Runquankang Biotechnology Co., Ltd. All rights reserved

| SEO |

图片名称

图片名称

Address: Guantian Industrial Park, Chongyi , Ganzhou, Jiangxi

图片名称

Tel：0791-88610177

图片名称

Phone：15170676666

图片名称

Mail：info@rqkpharm.com

图片名称

图片名称

Scan code to view